A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment (Q24803679)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment	scientific article

Statements

scholarly article

0 references

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Jaya Satagopan

3

0 references

object named as

Mark E Robson

1

0 references

object named as

Larry Norton

9

0 references

William David Foulkes

object named as

William D Foulkes

12

0 references

11

object named as

Kenneth Offit

0 references

author name string

Pierre O Chappuis

2

0 references

Nora Wong

4

0 references

Jeff Boyd

5

0 references

John R Goffin

6

0 references

Clifford Hudis

7

0 references

David Roberge

8

0 references

Louis R Bégin

10

0 references

language of work or name

0 references

publication date

2004

0 references

Breast Cancer Research

0 references

6

0 references

1

0 references

R8-R17

0 references

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1186/BCR658

22 April 2017

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

22 April 2017

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

The contribution of inherited factors to the clinicopathological features and behavior of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 September 2017

Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

30 May 2018

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

30 May 2018

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

30 May 2018

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

30 May 2018

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics,BRCAmutations and oophorectomy

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

Hereditary breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

Epithelial lesions in prophylactic mastectomy specimens from women withBRCA mutations

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

21 January 2018

BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=314444

28 November 2018

Hereditary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and tumor characteristics of German hereditary breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis and clinical presentation of BRCA2-associated breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://pubmed.ncbi.nlm.nih.gov/14680495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unusual case of Smith-Lemli-Opitz syndrome "type II"

1 reference

https://api.crossref.org/works/10.1186%2FBCR658

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24803679&oldid=2175274470"